Cross Your Own Ocean: The story of a new tech start up
@elinhafdavieswww.elinhafdavies.co.uk
@aparitohealthwww.aparito.com
© Elin Haf Davies 2014 Page 12
The Mad Hatter:“Have I gone mad?”Alice: “I’m afraid so. You’re entirely bonkers.But I’ll tell you a secret. All the best people are.”
© Elin Haf Davies 2014 Page 17
www.nurseelin.co.uk
Exploration is the physical expression of the intellectual passion.
Apsley Cherry Garrad
www.nurseelin.co.uk
Duct tape is like the force.
It has a dark side and a light side…
and it holds the Universe together.
© Elin Haf Davies 2014 Page 25
“Nautical Nurses”
£190,000 raised for
metabolic research at
Great Ormond Street
Children’s Hospital
£190,000 towards a PhD programme
Dr Emma Footitt
graduated August 2014
Pyridoxamine 5’-phoshate oxidase (PNPO) deficiency
© Elin Haf Davies 2014 Page 27
Orphan Designation by European Medicine Agency
Honoured to support:Prof Peter Clayton, Dr Emma Footitt, Dr Phillipa Mills, Dr Catherine Tuleu and Dr Abeer Ahmed (SoPh).
© Elin Haf Davies 2014 Page 28
“Ocean Angels”
3,600 miles
78 days
15 hours
54 minutes.
World First &
Fastest Record!£26,000
raised for
A well-read woman is a dangerous creature. Lisa Kleypas
The many faces of Dr Elin!
Photo credit: Dr Kevin Mills
My Research Background
• Phase II, open-label, randomized, multi-centre trial to evaluate the safety and efficacy of “DRUG X” in neuronopathic Gaucher disease.
• Inclusion Criteria:
• Child is able to swallow a tablet
• Child is able to comply with study assessments
No Mum!Please don’t
make me visit Elin again!!
Saccadic Eye Movement Assessment
Using a video, infrared or scleral search coil technique
Patients face a screen and follow a target that jump on the screenaccording to a pseudo-random sequence. The subjects sit with head in chin cup andforehead against a head rest and faced a screen 1 meter away on which a red laser spot is back projected.
GAITRite™ Gait Analysis •Commercially available.
•Portable.
•Mat embedded with 16,128 sensors set 1.27 cm apart.
•Activated by mechanical pressure.
Reimbursement applications fail
Clinical trials fail
(inconclusive)
Capturing clinically meaningful
patient-data is challenging.
Clinical Trial challenges
© Elin Haf Davies 2014 Page 37
The Aparito solution
Vastly improved understanding of diseases Better, cheaper & faster drug development More participants & engagementIncreased chance of regulatory approval Higher patient empowerment & quality of life Lives Saved & Improved
Database
Pat
ien
tW
ear
able
Ap
p
Spo
nso
r
Clin
icia
n
Patient Generated Outcome
Data
Remote Disease
Monitoring
Passive Data
Capture
Continuous Data
Real Time Data
Paperless Data
Capture
DigitalisedMonitoring
Process
Real Time Flags
Medication Prompts
Designed to overcome clinical & regulatory roadblocks
© Elin Haf Davies 2014 Page 38
Current & Completed Trials
NIEMANNPICK C
JUVENILEIDIOPATHICARTHRITIS
DUCHENNEMUSCULARDYSTROPHY
GAUCHERDISEASE
LATEONSET TAY
SACHS
CHILDOOD EPILEPSY
www.aparito.com
@aparitohealth
Thank youwww.elinhafdavies.co.uk
@elinhafdavies
www.aparito.com
@aparitohealth
Basic Copyright Notice & Disclaimer
©2018 This presentation is copyright protected. All rights reserved. You may download or print out a hard copy for your private or internal use. You are not permitted to create any modifications or derivatives of this presentation without the prior written permission of the copyright owner.
This presentation is for information purposes only and contains non-binding indications. Any opinions or views expressed are of the author and do not necessarily represent those of Swiss Re. Swiss Re makes no warranties or representations as to the accuracy, comprehensiveness, timeliness or suitability of this presentation for a particular purpose. Anyone shall at its own risk interpret and employ this presentation without relying on it in isolation. In no event will Swiss Re be liable for any loss or damages of any kind, including any direct, indirect or consequential damages, arising out of or in connection with the use of this presentation.